Betaxolol and propranolol in glucagon stimulation of growth hormone, Arch Dis Child, vol.59, pp.670-672, 1984. ,
I.v. glucagon use in Pediatric MR enterography: effect on image quality, length of examination, and patient tolerance, AJR Am J Roentgenol, vol.201, pp.185-189, 2013. ,
Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine, J Dermatol Sci, vol.52, pp.170-177, 2008. ,
, , 1990.
, The Authors, Pharmacology Research & Perspectives, 2015.
Interaction of the antiemetic metopimazine and anticancer agents with brain dopamine D2, 5-hydroxytryptamine3, histamine H1, muscarine cholinergic and a1-adrenaregic receptors, Cancer Chemother Pharmacol, vol.33, pp.53-56, 1993. ,
Bioavailability of the antiemetic metopimazine given as a microenema, Br J Clin Pharmacol, vol.41, pp.613-615, 1996. ,
Dose-finding study of oral metopimazine, Support Care Cancer, vol.5, pp.38-43, 1997. ,
Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood brain barrier, Pharmacol Res, vol.56, pp.11-17, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00543519
, The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, vol.3, pp.130-137, 2015.